3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Conditions
HIV Infections
2
Sarcoma, Kaposi
1
Lymphoma, AIDS-Related
1
Dendritic Cell Sarcoma, Interdigitating
1
Acquired Immunodeficiency Syndrome
1
Interventions
Etoposide
5
Cyclophosphamide
5
Vincristine
4
Rituximab
4
Prednisone
4
Filgrastim
3
Doxorubicin
3
Procarbazine
2
Lomustine
2
efavirenz
1
VAP-cyclo protocol
1
Radiotherapy
1
Peripheral Blood Stem Cell Transplantation
1
Mitoguazone
1
Melphalan
1
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
1
Cytarabine
1
Carmustine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Lymphoma, AIDS-Related
×
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
×
Clear all
NCT00799136
2013-09-12
CATCH
Ontario Clinical Oncology Group (OCOG)
Phase 2
Completed
6 enrolled